Disclosure Of Income Tax [Text Block]

Innate Pharma - Filing #2813423

Concept	2022-01-01 to 2022-12-31	As at 2022-12-31	2021-01-01 to 2021-12-31	As at 2021-12-31
Disclosure of income tax [text block]	Impôts sur les bénéfices	—	—	—
Major components of tax expense (income) [abstract]
Tax expense (income)	— EUR	—	— EUR	—
Disclosure of temporary difference, unused tax losses and unused tax credits [text block]	—	—	—	—
Disclosure of temporary difference, unused tax losses and unused tax credits [abstract]
Disclosure of temporary difference, unused tax losses and unused tax credits [line items]
Deferred tax assets and liabilities [abstract]
Deferred tax assets	—	8 568 EUR	—	5 028 EUR
Deferred tax liabilities	—	8 568 EUR	—	5 028 EUR
Reconciliation of accounting profit multiplied by applicable tax rates [abstract]